Attijariwafa bank SA (CBSE:ATW)

Oncternal Therapeutics Revenue

Attijariwafa bank had revenue of 8.23B MAD in the quarter ending June 30, 2025, with 12.31% growth. This brings the company's revenue in the last twelve months to 31.93B, up 12.00% year-over-year. In the year 2024, Attijariwafa bank had annual revenue of 30.42B with 17.17% growth.

• Revenue (ttm): 31.93B
• Revenue Growth: +12.00%
• P/S Ratio: 4.85
• Revenue / Employee: 1.50M
• Employees: 21,293
• Market Cap: 154.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	30.42B	4.46B	17.17%
Dec 31, 2023	25.96B	3.29B	14.51%
Dec 31, 2022	22.67B	1.94B	9.36%
Dec 31, 2021	20.73B	2.40B	13.08%
Dec 31, 2020	18.33B	-3.58B	-16.34%